INFUSYSTEMS HLDG.DL-0001
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of va… Read more
INFUSYSTEMS HLDG.DL-0001 (1TZ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INFUSYSTEMS HLDG.DL-0001 (1TZ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INFUSYSTEMS HLDG.DL-0001 - Net Assets Trend (None–None)
This chart illustrates how INFUSYSTEMS HLDG.DL-0001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INFUSYSTEMS HLDG.DL-0001 (None–None)
The table below shows the annual net assets of INFUSYSTEMS HLDG.DL-0001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INFUSYSTEMS HLDG.DL-0001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INFUSYSTEMS HLDG.DL-0001 Competitors by Market Cap
The table below lists competitors of INFUSYSTEMS HLDG.DL-0001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Fennec Pharmaceuticals Inc
NASDAQ:FENC
|
$134.57 Million |
|
Avalue Technology
TWO:3479
|
$134.61 Million |
|
Hainan Yedao Group Co Ltd
SHG:600238
|
$134.63 Million |
|
ZYF Lopsking Aluminum Co Ltd
SHE:002333
|
$134.65 Million |
|
Modiv Inc
NYSE:MDV
|
$134.52 Million |
|
Gaotu Techedu Inc
F:18WA
|
$134.39 Million |
|
Cahya Mata Sarawak Berhad
PINK:CHYMF
|
$134.39 Million |
|
Socep Constant
RO:SOCP
|
$134.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INFUSYSTEMS HLDG.DL-0001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INFUSYSTEMS HLDG.DL-0001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INFUSYSTEMS HLDG.DL-0001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INFUSYSTEMS HLDG.DL-0001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INFUSYSTEMS HLDG.DL-0001 (1TZ) | €- | N/A | N/A | $134.55 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.30 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $42.41 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.72 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $620.14 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |